Zydus Cadila gets USFDA nod to market muscle spasms tablets

Zydus Cadila gets USFDA nod to market muscle spasms tablets The company has received final approval from the United States Food and Drug Administration (USFDA) to market Baclofen tablets in the strength of 5 mg, Zydus Cadila said in a statement.

No comments:

Post a Comment